Related Experiment Video
Updated: Jun 5, 2026
06:13
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
Endoscopic resection of sinonasal malignancies
Piero Nicolai1, Paolo Castelnuovo, Andrea Bolzoni Villaret
1Department of Otorhinolaryngology, University of Brescia, Piazza Spedali Civili 1, 25123, Brescia, Italy. pieronicolai@virgilio.it
Current Oncology Reports
|January 19, 2011
Summary
Endoscopic resection offers advantages for sinonasal tract tumors, including less invasive surgery and faster recovery. Further research is needed to confirm long-term oncologic outcomes compared to traditional methods.
Area of Science:
- Oncology
- Otolaryngology
- Surgical Innovation
Background:
- Malignant sinonasal tumors are rare, comprising 1% of all malignancies.
- These tumors exhibit significant histological diversity, impacting treatment strategies.
- Surgery is a cornerstone in managing sinonasal tract malignancies.
Purpose of the Study:
- To review the evolution of sinonasal tumor treatments.
- To evaluate the impact of introducing endoscopic resection techniques.
- To compare endoscopic approaches with traditional external surgical methods.
Main Methods:
- Literature review focusing on surgical management of sinonasal malignancies.
- Analysis of advantages and disadvantages of endoscopic versus external surgical approaches.
- Discussion of oncologic outcomes and follow-up data.
Main Results:
- Endoscopic resection offers benefits like no facial incisions, reduced hospitalization, better bleeding control, and improved visualization.
- Endoscopic techniques are associated with decreased morbidity and mortality rates.
- Concerns remain regarding long-term oncologic results due to short/intermediate follow-up and pooled data from heterogeneous histologies.
Conclusions:
- Endoscopic resection presents significant advantages over traditional external approaches for sinonasal tumors.
- Further investigation, potentially through a large database, is crucial to validate oncologic outcomes.
- Addressing ethical and logistical challenges is necessary for comparative prospective studies.
